Covered recipient · General Payments record
KARRIN E LICHT
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2023–2024
$308.42
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $286.04 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $138.28 | 7 |
| Lilly USA, LLC | $33.14 | 2 |
| Novo Nordisk AS | $32.18 | 2 |
| Corium, Inc. | $21.21 | 1 |
| PFIZER INC. | $16.63 | 1 |
| E.R. Squibb & Sons, L.L.C. | $16.43 | 1 |
| Acerta Pharma LLC | $14.16 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.86 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104879883 | CMS |
| ABBVIE INC. | $3.46 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104879885 | CMS |
| ABBVIE INC. | $30.69 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104879887 | CMS |
| ABBVIE INC. | $20.37 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104879889 | CMS |
| ABBVIE INC. | $18.63 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104879891 | CMS |
| ABBVIE INC. | $26.21 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104879893 | CMS |
| ABBVIE INC. | $17.06 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104879895 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.16 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353211 | CMS |
| Corium, LLC | $21.21 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100181166 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.43 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101816813 | CMS |
| Lilly USA, LLC | $13.32 | 09/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135076397 | CMS |
| Lilly USA, LLC | $19.82 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135118069 | CMS |
| Novo Nordisk Inc | $15.32 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097559123 | CMS |
| Novo Nordisk Inc | $16.86 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097062308 | CMS |
| PFIZER INC. | $16.63 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130874802 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.01 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137620126 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.